The NADase CD38 is a central regulator in gouty inflammation and a novel druggable therapeutic target.
Paulo Gil AlabarsePatricia OliveiraHuaping QinTiffany YanMarie MigaudRobert TerkeltaubRu Liu-BryanPublished in: Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2024)
are potentially novel selective molecular approaches to limit gouty arthritis.